Walder Wyss advised Vandria SA in this transaction. Vandria SA, a company developing mitochondrial therapeutics, including first-in-class small molecule mitophagy inducers, today emerged from stealth with...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here